FR1500996A - Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non - Google Patents

Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non

Info

Publication number
FR1500996A
FR1500996A FR75433A FR75433A FR1500996A FR 1500996 A FR1500996 A FR 1500996A FR 75433 A FR75433 A FR 75433A FR 75433 A FR75433 A FR 75433A FR 1500996 A FR1500996 A FR 1500996A
Authority
FR
France
Prior art keywords
preparation
aqueous solvent
medicinal capsules
hydroxyalkylcellulose ethers
hydroxyalkylcellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR75433A
Other languages
English (en)
French (fr)
Inventor
George King Greminger Jr
Lewis Eugene Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of FR1500996A publication Critical patent/FR1500996A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/077—Manufacturing capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00—Special receptacle or package
    • Y10S206/828—Medicinal content

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Furnace Details (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FR75433A 1965-09-07 1966-09-06 Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non Expired FR1500996A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48561665A 1965-09-07 1965-09-07
US48561565A 1965-09-07 1965-09-07

Publications (1)

Publication Number Publication Date
FR1500996A true FR1500996A (fr) 1967-11-10

Family

ID=27048417

Family Applications (1)

Application Number Title Priority Date Filing Date
FR75433A Expired FR1500996A (fr) 1965-09-07 1966-09-06 Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non

Country Status (8)

Country Link
US (1) US3493407A (show.php)
BE (1) BE686537A (show.php)
DE (1) DE1617432C2 (show.php)
FR (1) FR1500996A (show.php)
GB (1) GB1144225A (show.php)
NL (1) NL6612510A (show.php)
NO (1) NO122091B (show.php)
SE (1) SE337654B (show.php)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073288A2 (show.php) * 1969-12-26 1971-10-01 Midy Claude Ctre Rech
CN113244187A (zh) * 2021-05-13 2021-08-13 青岛益青生物科技股份有限公司 一种新配方肠溶羟丙甲纤维素空心胶囊及其制备方法

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3617588A (en) * 1969-06-16 1971-11-02 Dow Chemical Co Dip-coating process for preparing cellulose ether capsule shells
US3839319A (en) * 1973-01-26 1974-10-01 Dow Chemical Co Hydroxypropyl methylcellulose ethers and method of preparation
SE403782B (sv) * 1973-03-14 1978-09-04 Mo Och Domsjoe Ab Nonjoniska cellulosaetrar
US3873518A (en) * 1973-12-14 1975-03-25 Dow Chemical Co Water soluble ternary cellulose ethers
CA1045976A (en) * 1974-05-02 1979-01-09 William J. Asher Liquid membrane encapsulated medicinals and uses thereof
US4001211A (en) * 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
DE2554558C3 (de) * 1975-12-04 1981-11-05 Hoechst Ag, 6000 Frankfurt Verfahren zum Beschichten eines Bandes aus hydrophilem Material mit Puder aus einem modifizierten Celluloseether
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4365060A (en) * 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
US4790881A (en) * 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
US4614545A (en) * 1985-08-15 1986-09-30 The Dow Chemical Company Hydroxypropyl methyl cellulose thickening agents for organic liquids
DE3674234D1 (de) 1985-02-28 1990-10-25 Dow Chemical Co Hydroxypropylmethylcellulose verwendbar als suspendierungsmittel fuer die perlpolymerisation von vinylchlorid.
KR900000254B1 (ko) * 1986-05-12 1990-01-24 신에쯔까 가가꾸 고우교우 가부시끼가이샤 의약용 경질 캅셀의 제조방법과 그 제조장치
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
FR2757173A1 (fr) * 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
GB2366780A (en) * 2000-07-07 2002-03-20 Bioprogress Tech Int Inc Foam capsules
MXPA01007406A (es) * 2000-07-20 2003-05-19 Du Pont Canada Recubrimiento de liberacion a alta temperatura y a alta humedad para una pelicula polimerica.
GB0210859D0 (en) * 2002-05-13 2002-06-19 Bioprogress Technology Ltd Modified polymeric films
GB0314832D0 (en) * 2003-06-25 2003-07-30 Phoqus Pharmaceuticals Ltd Production of capsule shells and capsules
EP1752140A1 (en) * 2005-08-12 2007-02-14 Warner-Lambert Company LLC Method for banding hard capsules using hydroxypropylmethyl cellulose (HPMC) as a base
US20100168410A1 (en) * 2006-10-27 2010-07-01 Pfizer Products Inc. Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
WO2011027258A2 (en) * 2009-09-04 2011-03-10 Pfizer Inc. Scented capsules
KR101762460B1 (ko) 2009-09-24 2017-07-27 캡슈겔 벨지엄 엔브이 내산성 캡슐
BR112013005642B1 (pt) 2010-10-12 2021-12-07 Nutrition & Biosciences Usa 1, Llc Éter de celulose, composição aquosa para a manufatura de cápsulas ou revestimentos, processo para a manufatura de cápsulas, processo para revestir uma forma de dosagem, invólucro de cápsula, cápsula e forma de dosagem
EP3354335A1 (en) 2010-10-26 2018-08-01 Capsugel Belgium NV Bulk enteric capsule shells
BR112014021506B1 (pt) 2012-04-11 2020-06-16 Dow Global Technologies Llc Composição líquida, uso de uma composição líquida, dispersão de sólidos, processo para revestir uma forma de dosagem e processo para a manufatura de cápsulas
ES2728850T3 (es) 2012-05-02 2019-10-29 Capsugel Belgium Nv Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS)
IN2015DN00427A (show.php) * 2012-07-23 2015-06-19 Samsung Fine Chemicals Co Ltd
KR20140072716A (ko) * 2012-12-05 2014-06-13 삼성정밀화학 주식회사 헤이즈가 개선된 필름
KR102085330B1 (ko) * 2012-12-05 2020-03-05 롯데정밀화학 주식회사 두께 균일성이 개선된 경질 캡슐
KR20140072715A (ko) * 2012-12-05 2014-06-13 삼성정밀화학 주식회사 경질 캡슐
US20160015647A1 (en) 2013-03-07 2016-01-21 Capsugel Belgium Nv Bismuth liquid filled hard capsules
KR20160058840A (ko) 2013-09-25 2016-05-25 다우 글로벌 테크놀로지스 엘엘씨 유기 액체 희석제 및 특정의 하이드록시알킬 메틸셀룰로오스를 포함하는 조성물
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
WO2015084696A1 (en) * 2013-12-04 2015-06-11 Dow Global Technologies Llc Process for preparing a mixture of a cellulose derivative and a liquid diluent
KR102199596B1 (ko) * 2013-12-31 2021-01-07 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
KR102199595B1 (ko) * 2013-12-31 2021-01-07 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
KR102161001B1 (ko) * 2013-12-31 2020-09-29 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
JP6412853B2 (ja) * 2015-12-16 2018-10-24 信越化学工業株式会社 フィルム成型用組成物
WO2019178698A1 (en) 2018-03-21 2019-09-26 Ryan Selby Vaporizer capsules and methods of manufacture
US12465075B2 (en) 2019-12-10 2025-11-11 Lonza Sales Ag Particles containing a lipid matrix core and active ingredient
AU2021213722A1 (en) 2020-01-29 2022-07-28 Lonza Greenwood Llc Joint health composition and use thereof in healthy mammals
EP4472608A1 (en) 2022-03-07 2024-12-11 Lonza Greenwood LLC Method and composition for improving skin health
KR20230173034A (ko) 2022-06-16 2023-12-26 신에쓰 가가꾸 고교 가부시끼가이샤 액체 조성물
WO2024026067A1 (en) 2022-07-29 2024-02-01 Lonza Greenwood Llc Method and composition for treating conditions associated with a leaky gut barrier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB643853A (en) * 1946-04-13 1950-09-27 Lilly Co Eli Medicinal capsules and process of manufacture

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073288A2 (show.php) * 1969-12-26 1971-10-01 Midy Claude Ctre Rech
CN113244187A (zh) * 2021-05-13 2021-08-13 青岛益青生物科技股份有限公司 一种新配方肠溶羟丙甲纤维素空心胶囊及其制备方法

Also Published As

Publication number Publication date
NL6612510A (show.php) 1967-03-08
DE1617432C2 (de) 1978-09-28
DE1617432B1 (de) 1972-05-31
NO122091B (show.php) 1971-05-18
GB1144225A (en) 1969-03-05
SE337654B (show.php) 1971-08-16
BE686537A (show.php) 1967-03-07
US3493407A (en) 1970-02-03

Similar Documents

Publication Publication Date Title
FR1500996A (fr) Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
NO812224L (no) Pustedrevet anordning for administrering av pulverformige medikamenter.
NL156922B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat met een coronaire werkzaamheid, gevormd farmaceutisch preparaat, verkregen met toepassing van deze werkwijze en werkwijze ter bereiding van coronair werkzame verbindingen geschikt voor gebruik bij de eerstgenoemde werkwijze.
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
IT965472B (it) Sistema ottico per il rapido controllo di capsule medicinali
CH538281A (fr) Capsule pharmaceutique verrouillée
NL154517B (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat werkzaam als hematicum en een werkwijze voor de bereiding van een als zodanig werkzame verbinding.
NL140526B (nl) Werkwijze voor de bereiding van farmacologisch werkzame dibenzothiazepinen, werkwijze voor de bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
OA03371A (fr) Procédé de préparation de médicaments antériques.
NL188948B (nl) Werkwijze ter bereiding van pyrido(1,2a)pyrimidines met werking tegen ontstekingen en tegen bloedstolling en werkwijze voor de bereiding van farmaceuttische preparaten die deze bevatten.
CH487921A (fr) Procédé de préparation de nouvelles substances physiologiquement actives
OA03357A (fr) Procédé de préparation de nouvelles chloroquinoléines.
NL172446B (nl) Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten.
NL142595B (nl) Werkwijze voor de bereiding van farmaceutische preparaten, die als werkzame stof triterpeensaponinen bevatten.
NL152169B (nl) Werkwijze ter bereiding van farmaceutische preparaten voor de behandeling van seborrhoea langs orale weg, alsmede aldus verkregen gevormde farmaceutische preparaten.
NL7416691A (nl) Werkwijze voor de bereiding van 17(alpha)-acyloxy-21- oxypregnanen, alsmede farmaceutische pre- en die deze verbindingen als actieve com- ten omvatten.
OA01792A (fr) Nouveaux composés alicycliques dérivés de la podophyllotoxine et leur préparation.
NL7608319A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.
NL142592B (nl) Werkwijze voor het bereiden van amidinen of daarvan afgeleide zuur-additiezouten, die werkzaam zijn als antagonisten van 5-hydroxytryptamine, en van farmaceutische preparaten, die ten minste een van deze verbindingen als werkzame verbinding bevatten.
OA02648A (fr) Glucosides dérivant de composés apparentés à la podophyllotoxine et leur préparation.
OA01758A (fr) Procédé pour la préparation de compositions pharmaceutiques.
OA01492A (fr) Préparation de monothiocarbonates d'alcoylènes.
CA842687A (en) Preparation of medicinal capsules from hydroxyalkylcellulose ethers using an aqueous or non-aqueous solvent
FR1462247A (fr) Procédé de préparation d'époxydes d'alcanes-1, 2